Skip to main content

Table 5 Impact of different genotypes on over all treatment outcomes

From: Influence of cytochrome P450 and glutathione S transferase polymorphisms on response to nilotinib therapy among chronic myeloidleukemia patients from Pakistan

Treatment outcome

Genotype

CYP1A1

GSTP1

GSTM1/GSTT1 combined genotype

AA (a)

AG (b)

GG (c)

P-value (a vs b vs c)

Ile/Ile (a)

Ile/Val (b)

Val/Val (c)

P-value (a vs b vs c)

WT

(a)

M āˆ’ (b)

T ā€“

(c)

M āˆ’/Tāˆ’

(d)

P-value (a vs b vs c vs d)

Responders (nā€‰=ā€‰66)

45

6

15

0.05

42

21

3

0.001

18

27

15

6

0.032

Partial Responders (nā€‰=ā€‰21)

9

9

3

0.001

9

12

0

0.034

15

6

0

0

0.001

Non-Responders (nā€‰=ā€‰12)

9

0

3

0.295

0

3

9

0.001

3

3

6

0

0.068